| 000 | 01611 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250510210005.0 | ||
| 264 | 0 | _c19760427 | |
| 008 | 197604s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(76)90218-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHuskisson, E C | |
| 245 | 0 | 0 |
_aImmunostimulant therapy with levamisole for rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cFeb 1976 |
||
| 300 |
_a393-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aCell Migration Inhibition |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aComplement System Proteins |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Delayed _xdiagnosis |
| 650 | 0 | 4 |
_aImmunity, Cellular _xdrug effects |
| 650 | 0 | 4 |
_aImmunoglobulins _xanalysis |
| 650 | 0 | 4 |
_aLevamisole _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPenicillamine _xtherapeutic use |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSkin Tests |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aScott, J | |
| 700 | 1 | _aBalme, H W | |
| 700 | 1 | _aDieppe, P A | |
| 700 | 1 | _aTrapnell, J | |
| 700 | 1 | _aWilloughby, D A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 7956 _gp. 393-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(76)90218-x _zAvailable from publisher's website |
| 999 |
_c54418 _d54418 |
||